|Mr. Fredrik Rågmark||CEO & Director||1.03M||N/A||1963|
|Mr. Joe Ryan||Chief Financial Officer||N/A||N/A||1965|
|Mr. Jaroslaw Urbanczyk||Chief Information Officer||N/A||N/A||1968|
|Hanna Bjellquist||Head of Investor Relations||N/A||N/A||N/A|
|Ms. Jenny Brandt||General Legal Counsel||N/A||N/A||1974|
|Dr. Andrew Vallance-Owen||Chief Marketing Officer||N/A||N/A||1951|
|Ms. Liselotte Bergmark||Group Human Resource Director||N/A||N/A||1966|
|Mr. John Paul Stubbington||Chief Operating Officer of Healthcare Services||N/A||N/A||1968|
|Mr. Staffan Ternstrom||Chief Operating Officer for Diagnostic Services||N/A||N/A||1965|
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Germany, Romania, India, Sweden, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Medicover AB (publ)’s ISS governance QualityScore as of 1 December 2023 is 5. The pillar scores are Audit: 1; Board: 7; Shareholder rights: 9; Compensation: 5.